Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AATC NASDAQ:BNGO NASDAQ:DAIO NASDAQ:PRPO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAATCAutoscope Technologies$5.51-0.5%$5.41$5.05▼$7.75$30.39M0.374,737 shs445 shsBNGOBionano Genomics$1.11$1.17$1.06▼$5.50$12.74M1.62116,785 shs100,217 shsDAIOData I/O$3.12-0.6%$3.61$2.16▼$4.49$29.31M1.2641,919 shs44,269 shsPRPOPrecipio$23.68+3.5%$23.72$13.80▼$33.63$42.33M1.2788,540 shs38,478 shsThe 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAATCAutoscope Technologies0.00%+1.47%+4.55%-1.18%-26.24%BNGOBionano Genomics0.00%-3.48%-0.89%-8.26%-68.29%DAIOData I/O0.00%-6.87%-16.13%+13.87%-3.70%PRPOPrecipio0.00%-3.90%+5.67%-15.41%+61.31%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAATCAutoscope Technologies$5.51-0.5%$5.41$5.05▼$7.75$30.39M0.374,737 shs445 shsBNGOBionano Genomics$1.11$1.17$1.06▼$5.50$12.74M1.62116,785 shs100,217 shsDAIOData I/O$3.12-0.6%$3.61$2.16▼$4.49$29.31M1.2641,919 shs44,269 shsPRPOPrecipio$23.68+3.5%$23.72$13.80▼$33.63$42.33M1.2788,540 shs38,478 shsThe 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAATCAutoscope Technologies0.00%+1.47%+4.55%-1.18%-26.24%BNGOBionano Genomics0.00%-3.48%-0.89%-8.26%-68.29%DAIOData I/O0.00%-6.87%-16.13%+13.87%-3.70%PRPOPrecipio0.00%-3.90%+5.67%-15.41%+61.31%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAATCAutoscope Technologies 0.00N/AN/AN/ABNGOBionano Genomics 2.00Hold$6.00440.54% UpsideDAIOData I/O 2.80Moderate Buy$5.1163.78% UpsidePRPOPrecipio 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest BNGO, PRPO, DAIO, and AATC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/24/2026DAIOData I/O LADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy7/17/2026DAIOData I/O Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)7/17/2026PRPOPrecipio Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)5/8/2026DAIOData I/O Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold5/6/2026DAIOData I/O LADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy5/1/2026BNGOBionano Genomics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E) ➝ Sell (E+)(Data available from 7/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAATCAutoscope Technologies$8.93M3.40$0.66 per share8.38$4.13 per share1.33BNGOBionano Genomics$28.51M0.45N/AN/A$4.37 per share0.25DAIOData I/O$21.50M1.36N/AN/A$1.44 per share2.17PRPOPrecipio$24.05M1.76$0.79 per share29.80$8.31 per share2.85Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAATCAutoscope Technologies$6.62M$0.256.26N/AN/A37.59%27.06%23.97%N/ABNGOBionano Genomics-$26.40M-$4.37N/AN/AN/A-109.94%-71.38%-43.07%8/13/2026 (Estimated)DAIOData I/O-$5.24M-$0.84N/AN/AN/A-41.85%-54.33%-36.75%7/30/2026 (Estimated)PRPOPrecipio-$360K-$0.47N/AN/AN/A-3.57%-6.73%-4.49%7/29/2026 (Estimated)Latest BNGO, PRPO, DAIO, and AATC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2026Q2 2026BNGOBionano Genomics-$0.70N/AN/AN/A$7.55 millionN/A7/29/2026Q2 2026PRPOPrecipio-$2.00N/AN/AN/A$1.68 millionN/A5/15/2026Q1 2026 & M&A AnnouncementDAIOData I/O-$0.16-$0.34-$0.18-$0.34$4.00 million$3.25 million5/14/2026Q1 2026PRPOPrecipioN/A-$0.81N/A-$0.81N/A$6.71 million5/13/2026Q1 2026BNGOBionano Genomics-$0.88-$0.7610+$0.1190-$0.76$6.57 million$6.69 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAATCAutoscope Technologies$0.6010.89%N/A240.00%1 YearsBNGOBionano GenomicsN/AN/AN/AN/AN/ADAIOData I/ON/AN/AN/AN/AN/APRPOPrecipioN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAATCAutoscope Technologies0.0925.7020.50BNGOBionano Genomics0.091.841.59DAIOData I/ON/A2.641.55PRPOPrecipio0.051.561.33Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAATCAutoscope TechnologiesN/ABNGOBionano Genomics11.35%DAIOData I/O36.95%PRPOPrecipio10.45%Insider OwnershipCompanyInsider OwnershipAATCAutoscope Technologies21.60%BNGOBionano Genomics0.65%DAIOData I/O4.06%PRPOPrecipio16.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAATCAutoscope Technologies405.52 million4.30 millionNot OptionableBNGOBionano Genomics30011.48 million11.40 millionNo DataDAIOData I/O1009.39 million9.01 millionOptionablePRPOPrecipio601.79 million1.49 millionNo DataBNGO, PRPO, DAIO, and AATC HeadlinesRecent News About These CompaniesPrecipio Earnings Estimates, EPS & Revenue | NASDAQ:PRPOJuly 21, 2026 | benzinga.comPRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy?July 16, 2026 | zacks.comPrecipio (NASDAQ:PRPO) Stock Passes Below 200-Day Moving Average - Should You Sell?July 16, 2026 | americanbankingnews.comPrecipio Inc.June 28, 2026 | marketwatch.comTop analyst reports for Caterpillar, Palo Alto & ToyotaJune 26, 2026 | msn.comPrecipio Shareholders Back Board Nominees and AuditorJune 15, 2026 | tipranks.comPrecipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders MeetingJune 12, 2026 | globenewswire.comPrecipio to Present at the Planet MicroCap Las VegasJune 11, 2026 | globenewswire.comPrecipio (PRPO) Q1 2026 Earnings Call TranscriptJune 2, 2026 | fool.comPrecipio (PRPO) Q4 2025 Earnings TranscriptJune 2, 2026 | aol.comAPrecipio Stock Slips Post Q1 Earnings Despite Revenue GrowthMay 22, 2026 | zacks.comPrecipio Inc (PRPO) Q1 2026 Earnings Call Highlights: Revenue Growth Amidst Margin ChallengesMay 20, 2026 | finance.yahoo.comPrecipio, Inc. (PRPO) Q1 2026 Earnings Call TranscriptMay 18, 2026 | seekingalpha.comPrecipio, Inc.: Precipio Announces Q1 2026 Financial ResultsMay 15, 2026 | finanznachrichten.dePrecipio Announces Q1 2026 Financial ResultsMay 14, 2026 | globenewswire.comManagement team’s 2025 market-based Options have vestedMay 14, 2026 | markets.businessinsider.comManagement team's 2025 market-based Options have vestedMay 13, 2026 | globenewswire.comThe Zacks Analyst Blog NVIDIA, Mastercard, AbbVie, Waterstone and PrecipioMay 13, 2026 | zacks.comB2i Digital Welcomes Precipio, Inc. as a New Featured CompanyMay 12, 2026 | tennessean.comTPrecipio Announces Q1-2026 Shareholder Update CallMay 6, 2026 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBNGO, PRPO, DAIO, and AATC Company DescriptionsAutoscope Technologies NASDAQ:AATC$5.51 -0.03 (-0.54%) As of 07/24/2026 02:04 PM EasternAutoscope Technologies Corporation develops and markets video and radar processing products for use in intersection control, highway, bridge and tunnel traffic management, and traffic data collection applications in the Asia Pacific, Europe, the Middle East, and North America. It operates in two segments, Intersection and Highway. The company provides Autoscope video systems that process video input from a traffic scene in real time and extracts the traffic data, including vehicle presence, bicycle presence/differentiation, counts, speed, length, time occupancy, turning movements, and flow rate; and RTMS radar systems that use radar to measure vehicle presence, volume, occupancy, speed, and classification information for roadway monitoring applications. It also offers IntellitraffiQ software that provides traffic measurement and data collection across large and small areas. The company markets and sells its products to end users comprising federal, state, city, and county departments of transportation, port, highway, tunnel, and other transportation authorities, as well as system integrators or other suppliers of systems and services who are operating under subcontracts in connection with road construction contracts. Autoscope Technologies Corporation was founded in 1984 and is headquartered in Minneapolis, Minnesota.Bionano Genomics NASDAQ:BNGO$1.11 0.00 (0.00%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$1.12 +0.01 (+0.90%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.Data I/O NASDAQ:DAIO$3.12 -0.02 (-0.64%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$3.16 +0.04 (+1.28%) As of 07/24/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Data I/O Corporation, together with its subsidiaries, engages in the design, manufacture, and sale of programming and security deployment systems and services for electronic device manufacturers in the United States, Europe, and internationally. Its programming system products are used to program integrated circuits (ICs) with the specific data for the ICs. The company offers PSV handlers off-line automated programming systems, such as PSV2800 automated programming system which focuses on high-volume manufacturing in a lower cost platform; PSV7000 automated programming system for security deployment upgrades; PSV5000 automated programming system that combines mid-range capacity and supports security deployment; and PSV3500 automated programming system which provides basic programming needs. It also provides SentriX security deployment system; and LumenX and non-automated FlashPAK III programming systems. In addition, the company offers hardware support, system installation and repair, and device programming services. It markets and sells its products to original equipment manufacturers in automotive and consumer electronics, internet of things, and industrial, as well as electronic manufacturing service contract manufacturers through direct sales, and indirect sales representatives and distributors. Data I/O Corporation was incorporated in 1969 and is headquartered in Redmond, Washington.Precipio NASDAQ:PRPO$23.68 +0.80 (+3.50%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$23.68 +0.00 (+0.02%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/20- 07/24 Telecom Earnings Reveal a Sector That Finally Looks Healthier AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Defense Earnings Show Readiness Now and Modernization Ahead Freeport McMoRan Post-Earnings: Why Good Enough May Finally Be Good Enough Tesla Just Delivered Record Sales—So Why Did the Stock Sell Off? Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
